Sorafenib - Wikipedia

Mechanism of action. Sorafenib is a small inhibitor of several tyrosine protein kinases, such as VEGFR, PDGFR and Raf family kinases (more avidly C-Raf than B-Raf).

Sorafenib - - CarcinomaEpatico.it - La Strada meno Battuta ...

Come agisce Nexavar? Il principio attivo di Nexavar, sorafenib, è un inibitore della protein-chinasi. Esso cioè blocca alcuni ...

Sorafenib – Wikipedia

Anwendungsgebiete und Zulassung. Sorafenib zählt zu den Orphan-Arzneimitteln und ist seit 2006 für einige wenige Indikationen in der EU zugelassen.

Sorafenib Uses, Side Effects & Warnings - Drugs.com

Physician reviewed sorafenib patient information - includes sorafenib description, dosage and directions.

Sorafenib (Nexavar) Chemotherapy Drug Information

Sorafenib (Nexavar) tyrosine kinase inhibitor targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of advanced ...

Nexavar (sorafenib) Uses, Dosage, Side Effects - Drugs.com

Nexavar is used to treat advanced renal cell carcinoma. Learn about side effects, interactions and indications.

Treatment With NEXAVAR (sorafenib)

Learn about NEXAVAR (sorafenib), including how it is thought to work, treatment options, and financial support.

Sorafenib in Advanced Hepatocellular Carcinoma | NEJM

Background No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase ...

Utilisation du sorafénib (Nexavar ® ) dans le traitement ...

Use of sorafenib (Nexavar ®) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations

TACTICS Trial Demonstrates Success With TACE Plus ...

Results of the randomized controlled TACTICS trial demonstrate that transcatheter arterial chemoembolization (TACE) in combination with sorafenib significantly ...